top of page
Founded in May 2021, SynapCon(c) GmbH develops advanced technologies and business models with a clear focus on accelerating the clinical development of drugs and medical devices.
We make products available to patients more quickly and reducing the burden on healthcare systems in the long term.
Thanks to the recent notice to sponsors from the EMA our product has never seen a better time to show off its capabilities.
We want to bring fast, efficient, affordable and reliable healthcare solutions to every human being on this planet. Clinical trials are one critical waypoint (or bottleneck) to pass for every IVD, drug or medical device manufacturer. This is why we decided to focus on improving these trials as a massive multiplication hub.
Based on our professional experience and the knowledge generated, a new development funded by the European Union was created from 2017 onwards. It implements the latest findings and requierements in IT and regulations as standards. Since 2021, the new systems are available and successfully in use to the full satisfaction of customers.
Dr. Carsten Mahrenholz,
CEO and Founder of Coldplasmatech GmbH
“The technical and regulatory expertise of
SynapCon is outstanding.“
Dr. Norbert Clemens, Director Clinical Trial Management EMEA at HOYA Surgical Optics GmbH
“The price-performance ratio in combination with the regulatory expertise is convincing.“
Best Clinical Trial Management System 2021
by Clinical Trial Management System & GHP Clinical Research Innovation Excellence Award 2021
Best Clinical Trial Management System 2022 Global
by M & A TODAY Global Awards 2022
Best Clinical Research Software Distributor 2022
by GHP Private Healthcare Awards 2022
Best Biotech Development Software Germany 2023
by Corporate LiveWire
bottom of page